Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01070342 · ClinicalTrials.gov registry record
Ambulatory Blood Pressure Monitoring in Children
A clinical trial of Blood Pressure, sponsored by University Hospitals Cleveland Medical Center.
- Completed
- Registry status
- 170
- Enrollment target
- 2
- Study locations
NCT01070342 is a study of Blood Pressure that has completed, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 170 participants, below the 285-participant average among 101 other Blood Pressure trials with a reported enrollment target (40% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT01070342, a study of Blood Pressure, has completed, sponsored by University Hospitals Cleveland Medical Center.
- COMPLETED
- Registry status
- 170 participants
- Enrollment target
- 2
- Study locations
Study Summary
Ambulatory Blood Pressure Monitoring (ABPM) potentially offers a superior way to screen children for entry into antihypertensive trials, assuring that only those with true hypertension are enrolled.10 In addition, ABPM offers a better method to measure response to drug therapy.11-16 The ABPM device most commonly used in children (Spacelabs 90217 - Issaquah, Washington) has not been independently validated for use in this population. In 1993, the British Hypertension Society (BHS) published a protocol for validating ABPM devices, including guidance for validation studies in children.17 More recently, the Working Group on Blood Pressure Monitoring of the European Society of Hypertension published revisions to these guidelines, but did not include children in this update.18 Unfortunately, the original BHS protocol suggests using a smaller group of children than the protocol outlines for adults. Since BP in children is more variable than in adults, this guidance is unlikely to be adequate for children. Hence, a large, stringent validation study needs to be conducted in a cohort of children using the methods similar to those used to validate the device in adults. Performance of the proposed validation study is needed to allow for the incorporation of ABPM into clinical trial designs of anti-hypertensives in children which will ultimately allow for more accurate identification of the hypertensive population and determination of response to therapy along with allowing for assessment of the chronobiologic profile of drug response over the dosing interval.9
Conditions Studied
Interventions
- DEVICE Spacelabs 90217
Study Locations (2)
Arkansas
- Arkansas Children's Hospital Research Institute - Little Rock
Kentucky
- University of Louisville Research Foundation, Inc. - Louisville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 170 participants |
| Start Date | 2010-02 |
| Est. Completion | 2011-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01070342
The ClinicalTrials.gov registry entry for NCT01070342 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 170 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 285-participant average among 101 other Blood Pressure trials with a reported enrollment target (40% lower). The listed sponsor is University Hospitals Cleveland Medical Center, which has 230 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Blood Pressure appearing as the primary indexed condition, and to 1 intervention - of which Spacelabs 90217 is the first listed.
NCT01070342 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Arkansas, Kentucky.
Frequently Asked Questions
What is clinical trial NCT01070342 about?
NCT01070342 is a clinical study titled "Ambulatory Blood Pressure Monitoring in Children". Ambulatory Blood Pressure Monitoring (ABPM) potentially offers a superior way to screen children for entry into antihypertensive trials, assuring that only those with true hypertension are enrolled.10 In addition, ABPM offers a better method to measure response to drug therapy.11-16 The ABPM device ...
What is the current status of trial NCT01070342?
This trial is currently completed. The enrollment target is 170 participants. The study started on 2010-02. Estimated completion is 2011-02.
What conditions does trial NCT01070342 study?
This clinical trial studies the following conditions: Blood Pressure.
What interventions are being tested in trial NCT01070342?
The interventions under investigation include: Spacelabs 90217 (DEVICE).
Who is sponsoring clinical trial NCT01070342?
This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01070342 being conducted?
This trial has 2 study locations across Arkansas, Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Blood Pressure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
RECRUITING
-
Autonomic Regulation of Blood Pressure in Premature and Early Menopausal Women
RECRUITING
-
Cocooned Moms Study
RECRUITING · NA
-
VicorderCS NIBP Validation Study to Review The Ability to Capture Blood Pressure Measurements
RECRUITING
-
The GUARDIAN Trial
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.